The deal ends 2Seventy’s short run as an independent company, during which it restructured, sold off research and lost nearly ...

Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, ...

Under the plans the company's rare disease drugs will remain under the aegis of bluebird with current genetic disease president Andrew Obenshain taking the reins as CEO. Meanwhile the as-yet ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...

Known as Zynteglo in Europe where it is approved to treat the rare blood disorder beta-thalassemia, the gene therapy has been given the all-clear by bluebird’s scientists after reviewing the ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit that the Swiss pharma ...

Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...

The Arizona bus envelops you in warmth and calmness with its organic design that blends natural materials, handcrafted ...

She worked mainly on TV but received fan mail for half a century for her appearance with horror stalwarts Boris Karloff and ...

Hello, wonderful readers! To continue and hopefully conclude this melancholic March, let’s look at “It’s a Blue World” by Mel Tormé, an album by a semi-popular and underrated vocalist from the ...

In a look ahead at a week of Cambridge and Somerville events, there’s a free pi day pie potluck, comedy against cancer, Mobius performance art called “Slay,” Ukrainian folk-rock, a St. Patrick’s fun ...

Georgia hides a 1,018-acre wonderland where history and nature create magic – Watson Mill Bridge State Park in Comer, where ...